Fordham University Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00138138
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fordham University

Active Ingredients

Drugs in Phase 4 Trials (2)

buprenorphine (1 trial)

methadone (methadose) (1 trial)

Drugs in Phase 2 Trials (1)

methylphenidate (ritalin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 2)

Opioid-Related Disorders (Phase 4)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3